Take our poll: How are you feeling as we near the New Year?
FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers
moderators
Posts: 8,741
FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers
Nov 17, 2023
Truqap is a new targeted therapy option for metastatic, hormone receptor-positive breast cancer with specific genetic mutations that has stopped responding to other hormonal therapy medicines. Read more…
q
Tagged:
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.